Perioperative immunotherapy for resectable hepatocellular carcinoma - Authors' reply.
APA
Liang F, Zhou S, et al. (2026). Perioperative immunotherapy for resectable hepatocellular carcinoma - Authors' reply.. Lancet (London, England), 407(10536), 1334. https://doi.org/10.1016/S0140-6736(26)00294-1
MLA
Liang F, et al.. "Perioperative immunotherapy for resectable hepatocellular carcinoma - Authors' reply.." Lancet (London, England), vol. 407, no. 10536, 2026, pp. 1334.
PMID
41936366
같은 제1저자의 인용 많은 논문 (3)
- Tumor diagnosis and therapy system based on covalent organic framework (COF): From sensing detection to synergistic treatment.
- Celecoxib pretreatment and nab-paclitaxel-associated acute pain syndrome in patients with breast cancer: a prospective, non-randomized controlled clinical study.
- An evaluation of plastic surgery resident selection factors.